NHS approves 'game changing' lung cancer drug

NHS approves 'game changing' lung cancer drug NHS drug watchdogs have today approved a 'game changing' drug for lung cancer patients.

Mobocertinib tablets will be given to patients battling a rare and aggressive form of the disease, Britain's biggest cancer killer.

Roughly 100 people will be eligible to take the drug every year, with doctors set to start to dishing it out within weeks. The Daily Mail

See also:

• NHS fast tracks new ‘gamechanging’ drug for lung cancer NHS England